Tapewire

OTC · USD

CYDY

CytoDyn Inc.

Export transactions ↓
Tapewire entity
5856
SEC CIK
0001175680
Parsed reports
267

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 20, 2026 Filed Mar 24, 2026 21:24 UTC GrantNon-qualified stock option (right to buy) · Derivative 574,385 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033963 · tm269618-8_4seq1.xml · derivative · entry 1

Urbach Tanya Durkee · CIK 0001897672 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,385

Underlying: Common Stock · 574,385 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:23 UTC GrantNon-qualified stock option (right to buy) · Derivative 574,385 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033962 · tm269618-7_4seq1.xml · derivative · entry 1

SIMES STEPHEN M · CIK 0000905479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,385

Underlying: Common Stock · 574,385 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:23 UTC GrantNon-qualified stock option (right to buy) · Derivative 574,385 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033961 · tm269618-6_4seq1.xml · derivative · entry 1

Ndhlovu Lishomwa C · CIK 0001898357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,385

Underlying: Common Stock · 574,385 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:22 UTC
Lalezari Jacob PChief Executive Officer
GrantNon-qualified stock option (right to buy) · Derivative 4,874,691 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033960 · tm269618-5_4seq1.xml · derivative · entry 1

Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,874,691

Underlying: Common Stock · 4,874,691 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: 1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:22 UTC
Hoffman Robert E.Chief Financial Officer
GrantNon-qualified stock option (right to buy) · Derivative 4,874,691 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033958 · tm269618-4_4seq1.xml · derivative · entry 1

Hoffman Robert E. · CIK 0001166288 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,874,691

Underlying: Common Stock · 4,874,691 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: 1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:21 UTC
Dunlap RyanDirector
GrantNon-qualified stock option (right to buy) · Derivative 574,385 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033957 · tm269618-3_4seq1.xml · derivative · entry 1

Dunlap Ryan · CIK 0001554742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,385

Underlying: Common Stock · 574,385 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:20 UTC GrantNon-qualified stock option (right to buy) · Derivative 574,385 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033955 · tm269618-2_4seq1.xml · derivative · entry 1

Brunke Karen J · CIK 0001922660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,385

Underlying: Common Stock · 574,385 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 21:20 UTC
Blok TylerChief Legal Officer
GrantNon-qualified stock option (right to buy) · Derivative 3,249,794 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001104659-26-033954 · tm269618-1_4seq1.xml · derivative · entry 1

Blok Tyler · CIK 0001990234 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,249,794

Underlying: Common Stock · 3,249,794 shares

Expires 2036-03-20

F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").

F2 · derivative.exercise_date: 812,448 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030.

Read SEC document
May 15, 2025 Filed May 23, 2025 00:31 UTC
Hoffman Robert E.Chief Financial Officer
GrantNon-qualified stock option (right to buy) · Derivative 1,000,000 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0001104659-25-052122 · tm2515909-2_4seq1.xml · derivative · entry 1

Hoffman Robert E. · CIK 0001166288 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2035-05-15

F1 · shares: This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan").

F2 · derivative.exercise_date: 250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:48 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112761 · tm2427081-7_4seq1.xml · derivative · entry 1

Urbach Tanya Durkee · CIK 0001897672 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:48 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112760 · tm2427081-6_4seq1.xml · derivative · entry 1

SIMES STEPHEN M · CIK 0000905479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:47 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112758 · tm2427081-5_4seq1.xml · derivative · entry 1

Ndhlovu Lishomwa C · CIK 0001898357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:46 UTC
Dunlap RyanDirector
GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112756 · tm2427081-3_4seq1.xml · derivative · entry 1

Dunlap Ryan · CIK 0001554742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:47 UTC
Lalezari Jacob PChief Executive Officer
GrantNon-qualified stock option (right to buy) · Derivative 3,000,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112757 · tm2427081-4_4seq1.xml · derivative · entry 1

Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 250,000 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:45 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112755 · tm2427081-2_4seq1.xml · derivative · entry 1

Brunke Karen J · CIK 0001922660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 01:45 UTC
Blok TylerChief Legal Officer
GrantNon-qualified stock option (right to buy) · Derivative 1,250,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001104659-24-112753 · tm2427081-1_4seq1.xml · derivative · entry 1

Blok Tyler · CIK 0001990234 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 1,250,000 shares

Expires 2034-10-28

F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.

F2 · derivative.exercise_date: 104,164 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028.

Read SEC document
March 07, 2024 Filed Mar 9, 2024 02:30 UTC
Lalezari Jacob PChief Executive Officer
GrantNon-qualified stock option (right to buy) · Derivative 3,000,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-032609 · tm248303-1_4seq1.xml · derivative · entry 1

Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2034-03-07

F1 · derivative.exercise_date: The stock option will vest and become exercisable in 48 monthly installments beginning on April 7, 2024 and ending on March 7, 2028, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 630,222 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 12

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 630,222

Underlying: Common Stock · 630,222 shares

Expires 2032-09-20

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F8 · derivative.exercise_date: 301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 1,000,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 11

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2031-08-06

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F7 · derivative.exercise_date: 666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 10

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-17

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F6 · derivative.exercise_date: 33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 9

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-07-22

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 8

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-02-21

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 7

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-01-16

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 630,222 Not disclosed Strike: $0.58 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 6

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 630,222 shares

Expires 2032-09-20

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F5 · derivative.exercise_date: 25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 1,000,000 Not disclosed Strike: $1.32 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 5

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000,000 shares

Expires 2031-08-06

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F4 · derivative.exercise_date: Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $5.54 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 4

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2031-02-17

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F3 · derivative.exercise_date: Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 100,000 Not disclosed Strike: $5.57 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 3

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2030-07-22

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $1.10 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 2

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2030-02-21

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC Disposition to issuerNon-qualified stock option (right to buy) · Derivative 50,000 Not disclosed Strike: $1.03 Not disclosed
Disclosure

SEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 1

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2030-01-16

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:03 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001954 · tm242134-5_4seq1.xml · derivative · entry 1

SIMES STEPHEN M · CIK 0000905479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001955 · tm242134-6_4seq1.xml · derivative · entry 2

Urbach Tanya Durkee · CIK 0001897672 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:02 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001953 · tm242134-4_4seq1.xml · derivative · entry 1

Ndhlovu Lishomwa C · CIK 0001898357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2024-01-03

F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:01 UTC GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001951 · tm242134-2_4seq1.xml · derivative · entry 1

Brunke Karen J · CIK 0001922660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:02 UTC
Dunlap RyanDirector
GrantNon-qualified stock option (right to buy) · Derivative 800,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001952 · tm242134-3_4seq1.xml · derivative · entry 1

Dunlap Ryan · CIK 0001554742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:01 UTC
Blok TylerEVP of Legal Affairs
GrantNon-qualified stock option (right to buy) · Derivative 1,000,000 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 4

Blok Tyler · CIK 0001990234 · EVP of Legal Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2034-01-03

F4 · derivative.exercise_date: 145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:01 UTC
Blok TylerEVP of Legal Affairs
GrantNon-qualified stock option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.21 Not disclosed
Disclosure

SEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 3

Blok Tyler · CIK 0001990234 · EVP of Legal Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-07-25

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F3 · derivative.exercise_date: 35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 02:01 UTC
Blok TylerEVP of Legal Affairs
Disposition to issuerNon-qualified stock option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.67 Not disclosed
Disclosure

SEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 2

Blok Tyler · CIK 0001990234 · EVP of Legal Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2032-07-25

F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: 25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 01:09 UTC GrantWarrants (right to buy) · Derivative 434,782 Not disclosed Strike: $0.50 Not disclosed
Disclosure

SEC source: 0001104659-23-022094 · tm236870-1_4seq1.xml · derivative · entry 2

Arman Arvin Cyrus · CIK 0001939191 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 434,782

Underlying: Common Stock · 434,782 shares

Expires not disclosed

F1 · shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock.

F2 · shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

F2 · price: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

F3 · derivative.exercise_date: The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date.

F3 · derivative.expiration_date: The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date.

F1 · derivative.underlying_shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock.

F2 · derivative.underlying_shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

F2 · balance_after: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 01:09 UTC GrantCommon Stock 434,782 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-022094 · tm236870-1_4seq1.xml · nonDerivative · entry 1

Arman Arvin Cyrus · CIK 0001939191 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,081,334

F1 · shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock.

F2 · shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

F2 · price: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

F2 · balance_after: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.

Read SEC document
November 30, 2022 Filed Dec 1, 2022 01:34 UTC GrantCommon Stock 12,008 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-123366 · tm2231600-4_4seq1.xml · nonDerivative · entry 1

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,207

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
November 30, 2022 Filed Dec 1, 2022 01:33 UTC GrantCommon Stock 16,927 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-123365 · tm2231600-3_4seq1.xml · nonDerivative · entry 1

Kelly Scott A. · CIK 0001703394 · CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184,037

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
November 28, 2022 Filed Dec 1, 2022 01:34 UTC GrantNon-qualified stock option (right to buy) · Derivative 4,585,536 $0.00 Strike: $0.35 $0.00
Disclosure

SEC source: 0001104659-22-123366 · tm2231600-4_4seq1.xml · derivative · entry 2

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,585,536

Underlying: Common Stock · 4,585,536 shares

Expires 2032-11-28

F2 · derivative.exercise_date: 477,660 shares vested on November 28, 2022; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from November 2022 through May 2026.

Read SEC document
November 28, 2022 Filed Dec 1, 2022 01:33 UTC GrantNon-qualified stock option (right to buy) · Derivative 2,315,439 $0.00 Strike: $0.35 $0.00
Disclosure

SEC source: 0001104659-22-123365 · tm2231600-3_4seq1.xml · derivative · entry 3

Kelly Scott A. · CIK 0001703394 · CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,315,439

Underlying: Common Stock · 2,315,439 shares

Expires 2032-11-28

F2 · derivative.exercise_date: 241,190 shares vested on November 28, 2022; the balance will vest on a monthly basis as follows (i) 48,238 shares at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended), from November 2022 through February 2025, and (ii) 48,239 shares at the conclusion of each month of Continuous Service, from March 2025 through May 2026.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:53 UTC GrantCommon Stock 10,807 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-119981 · tm2230762-3_4seq1.xml · nonDerivative · entry 1

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,199

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:51 UTC GrantCommon Stock 15,234 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-119979 · tm2230762-2_4seq1.xml · nonDerivative · entry 1

Kelly Scott A. · CIK 0001703394 · CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,167,110

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:49 UTC
Ray Nitya G.Chief Technology Officer
GrantCommon Stock 13,671 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-119978 · tm2230762-1_4seq1.xml · nonDerivative · entry 1

Ray Nitya G. · CIK 0001709522 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,090

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
October 31, 2022 Filed Nov 3, 2022 00:57 UTC GrantCommon Stock 17,922 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-114101 · tm2228860-4_4seq1.xml · nonDerivative · entry 1

Kelly Scott A. · CIK 0001703394 · CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,151,876

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
October 31, 2022 Filed Nov 3, 2022 00:55 UTC GrantCommon Stock 12,714 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-114100 · tm2228860-3_4seq1.xml · nonDerivative · entry 1

Migliarese Antonio · CIK 0001864040 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,392

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
October 31, 2022 Filed Nov 3, 2022 00:52 UTC
Ray Nitya G.Chief Technology Officer
GrantCommon Stock 16,084 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-114098 · tm2228860d2_4seq.xml · nonDerivative · entry 1

Ray Nitya G. · CIK 0001709522 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486,419

F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Read SEC document
October 24, 2022 Filed Nov 1, 2022 21:04 UTC GrantNon-qualified stock option (right to buy) · Derivative 178,012 $0.00 Strike: $0.43 $0.00
Disclosure

SEC source: 0001104659-22-113563 · tm2228860-1_4seq1.xml · derivative · entry 1

SIMES STEPHEN M · CIK 0000905479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,012

Underlying: Common Stock · 178,012 shares

Expires 2032-10-24

F1 · derivative.exercise_date: The options will vest in eight equal monthly installments beginning on November 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.